Last quarter (Q3 2025), Revelation Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Revelation Biosciences's net income was $-1.91M. See Revelation Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Expenses	$ 7.98M	$ 8.66M	$ 10.86M	$ 11.95M	$ 3.80M
Depreciation and Amortization	$ 27.92K	$ 25.05K	$ 25.05K	$ 16.78K	$ 3.80M
EBITDA	$ -7.95M	$ -8.63M	$ -10.84M	$ -11.93M	$ 0.00
Operating Income	$ -7.98M	$ -8.66M	$ -10.86M	$ -11.95M	$ -3.80M
Other Income/Expenses	$ -7.06M	$ 8.54M	$ 34.96K	$ -36.35K	$ 126.00
Pretax Income	$ -15.04M	$ -120.25K	$ -10.83M	$ -11.99M	$ -3.80M
Net Income	$ -15.04M	$ -120.25K	$ -10.83M	$ -11.99M	$ -3.80M
Per Share Metrics
Basic EPS	$ -87.68	$ -8.41	$ -9.64K	$ -20.40K	$ -9.03K
Diluted EPS	$ -87.68	$ -8.41	$ -9.64K	$ -20.40K	$ -9.03K
Weighted Average Shares Outstanding	171.51K	14.29K	1.12K	-	-
Weighted Average Shares Outstanding (Diluted)	171.51K	14.29K	1.12K	-	-

Currency in USD

Revelation Biosciences Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing